Mayne Pharma Group (Mayne Pharma Group) Operating Cash Flow per Share : $-1.16 (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Mayne Pharma Group Operating Cash Flow per Share?

Mayne Pharma Group's operating cash flow per share for the six months ended in Dec. 2023 was $-2.29. Mayne Pharma Group's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.16.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Mayne Pharma Group's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Mayne Pharma Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 62.00% per year. The lowest was -35.40% per year. And the median was 3.00% per year.

MYPHY's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.45
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Mayne Pharma Group Operating Cash Flow per Share Historical Data

The historical data trend for Mayne Pharma Group's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mayne Pharma Group Operating Cash Flow per Share Chart

Mayne Pharma Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

10.04

9.01

5.73

-0.62

-3.45

Mayne Pharma Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.04	-0.64	-4.65	1.13	-2.29

Competitive Comparison of Mayne Pharma Group's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, Mayne Pharma Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mayne Pharma Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mayne Pharma Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Mayne Pharma Group's Price-to-Operating-Cash-Flow falls into.

Mayne Pharma Group Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Mayne Pharma Group's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-28.666	/	8.316
	=	-3.45

Mayne Pharma Group's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-19.224	/	8.392
	=	-2.29

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.16

Mayne Pharma Group Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Mayne Pharma Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Mayne Pharma Group (Mayne Pharma Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mayne Pharma Group Ltd (OTCPK:MYPHY) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

MAYNF:USA HG6:Germany MYX:Australia

Address

1538 Main North Road, Salisbury South, Salisbury, SA, AUS, 5106

Website

http://www.maynepharma.com

Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Branded Products (BPD) and Portfolio Products Division (PPD). The Portfolio Products Division distributes dermatology products (branded and generic) in the US on a portfolio basis, The Branded Products Division distributes branded women's health products in the US. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.